AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31645472 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine administered intravenously to increase systolic blood pressure (SBP) up to 200 mm Hg
Number of subjects: 153
Study 31645472 — intervention group
Group type: COMPARATOR
Intervention: Control group (no induced hypertension)
Number of subjects: 153
Study 28193176 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (BP) alone
Number of subjects: 1110
Study 28193176 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure with telemonitoring
Number of subjects: 1110
Study 28193176 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1110
Study 27183072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrasulcular incision
Number of subjects: 40
Study 27183072 — intervention group
Group type: COMPARATOR
Intervention: Trapezoidal incision
Number of subjects: 40
Study 27183072 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sample analysis
Number of subjects: 40
Study 24626270 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression with a 10‐cmH2O increase in baseline inspiratory pressure on pressure support ventilation
Number of subjects: 34
Study 24626270 — intervention group
Group type: COMPARATOR
Intervention: Aspiration alone (control group)
Number of subjects: 34
Study 22395672 — intervention group
Group type: COMPARATOR
Intervention: HAART (stavudine, lamivudine, and nevirapine)
Number of subjects: 112
Study 22395672 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART and chemotherapy (CXT) (Triomune plus bleomycin, doxorubicin, and vincristine every 3 weeks, or oral etoposide when not available)
Number of subjects: 112
Study 22395672 — intervention group
Group type: COMPARATOR
Intervention: HAART (Control)
Number of subjects: 112
Study 22395672 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART and CXT (Experimental)
Number of subjects: 112
Study 19775480 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan-containing adjuvant chemotherapy
Number of subjects: 498
Study 19775480 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant 5-FU-based chemotherapy (including irinotecan)
Number of subjects: 498
Study 19775480 — intervention group
Group type: EXPERIMENTAL
Intervention: Topoisomerase I expression
Number of subjects: 498
Study 17213294 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 item stage of change (SOC) questionnaire administered prior to ART and after 16 weeks of treatment
Number of subjects: 31
Study 16366041 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum (thyme fluid extract and primrose root tincture)
Number of subjects: 150
Study 16366041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 16366041 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum
Number of subjects: 150
Study 17044538 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) applied with Merocel soaked with 1.5 mL of MMC (0.4 mg/mL) for 5 minutes
Number of subjects: 20
Study 17044538 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution applied as control
Number of subjects: 20
Study 10234495 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep anaesthesia removal of laryngeal mask airway
Number of subjects: 300
Study 10234495 — intervention group
Group type: COMPARATOR
Intervention: Awake removal of laryngeal mask airway
Number of subjects: 300
Study 10234495 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake removal of laryngeal mask airway in children < 6 years
Number of subjects: 300
Study 10234495 — intervention group
Group type: COMPARATOR
Intervention: Deep anaesthesia removal of laryngeal mask airway in children < 6 years
Number of subjects: 300
Study 8678002 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy plus omeprazole (amoxicillin 500 mg p.o., t.i.d.; metronidazole 250 mg p.o., t.i.d.; bismuth subsalicylate 524 mg p.o., q.i.d.; omeprazole 20 mg p.o., q.d.)
Number of subjects: 100
Study 8678002 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 100
Study 8678002 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy plus omeprazole
Number of subjects: 100
Study 8678002 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori-eradicated patients
Number of subjects: 100
Study 1668656 — intervention group
Group type: EXPERIMENTAL
Intervention: sCT 100 I.U. by nasal spray
Number of subjects: 6
Study 1668656 — intervention group
Group type: COMPARATOR
Intervention: sCT 50 I.U. by intramuscular route
Number of subjects: 6
Study 6346399 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 47
Study 6346399 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 31729520 — intervention group
Group type: EXPERIMENTAL
Intervention: Purple rice
Number of subjects: 24
Study 31729520 — intervention group
Group type: EXPERIMENTAL
Intervention: Yunlu29 (red rice)
Number of subjects: 24
Study 31729520 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice
Number of subjects: 24
Study 29879045 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingfeijianpi decoction (1 dose/day for 4 weeks)
Number of subjects: 101
Study 29879045 — intervention group
Group type: COMPARATOR
Intervention: Loratadine (10 mg once per day for 4 weeks)
Number of subjects: 101
Study 27149266 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 786
Study 27149266 — intervention group
Group type: EXPERIMENTAL
Intervention: DTPa and OPV (co-administered with RIX4414)
Number of subjects: 786
Study 27149266 — intervention group
Group type: EXPERIMENTAL
Intervention: OPV (co-administered with RIX4414)
Number of subjects: 786
Study 25227994 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Tryptophan Depletion (ATD)
Number of subjects: 5
Study 25227994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 22777514 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 149
Study 22777514 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (among etomidate-exposed patients)
Number of subjects: 149
Study 22777514 — intervention group
Group type: COMPARATOR
Intervention: Control (No etomidate)
Number of subjects: 149
Study 19815243 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg/d, n = 50)
Number of subjects: 100
Study 19815243 — intervention group
Group type: COMPARATOR
Intervention: Metformin (maximum dose 2550 mg/d, n = 50)
Number of subjects: 100
Study 16876479 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (G(1), N=6): 8 x 60% of T(max) at V.VO(2max), 1:1 work:recovery ratio
Number of subjects: 17
Study 16876479 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (G(2), N=6): 12 x 30s at 130% V.VO(2max), 4.5 min recovery
Number of subjects: 17
Study 16876479 — intervention group
Group type: COMPARATOR
Intervention: Control group (G(CON), N=5): 60 min at 75% V.VO(2max)
Number of subjects: 17
Study 16236956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low amount/moderate intensity (LAMI, n = 25)
Number of subjects: 133
Study 16236956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low amount/high intensity (LAHI, n = 36)
Number of subjects: 133
Study 16236956 — intervention group
Group type: EXPERIMENTAL
Intervention: High amount/high intensity (HAHI, n = 35)
Number of subjects: 133
Study 16236956 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 37)
Number of subjects: 133
Study 12119808 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment technique (ART) using hand instruments
Number of subjects: 0
Study 12119808 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment technique using rotary instruments
Number of subjects: 0
Study 12119808 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer cement restorations made with hand instruments
Number of subjects: 0
Study 12119808 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealant retention
Number of subjects: 0
Study 12119808 — intervention group
Group type: EXPERIMENTAL
Intervention: Operator variances
Number of subjects: 0
Study 9917435 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined vaccine (DTaP + PRP-T)
Number of subjects: 135
Study 9917435 — intervention group
Group type: COMPARATOR
Intervention: Separate vaccines (DTaP and PRP-T)
Number of subjects: 135
Study 7482998 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine 300 mg weekly combined with proguanil 100 mg daily
Number of subjects: 200
Study 7482998 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine 300 mg weekly combined with proguanil 200 mg daily
Number of subjects: 200
Study 7482998 — intervention group
Group type: EXPERIMENTAL
Intervention: Proguanil 200 mg daily only
Number of subjects: 200
Study 7482998 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 200
Study 7482998 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever incidence
Number of subjects: 200
Study 7482998 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance assessment
Number of subjects: 200
Study 31095461 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3‐ rich beetroot juice (12.9 mmol NO3‐)
Number of subjects: 12
Study 31095461 — intervention group
Group type: COMPARATOR
Intervention: NO3‐ depleted placebo (0.13 mmol NO3‐)
Number of subjects: 12
Study 28194729 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support tool and order set for inpatient physicians
Number of subjects: 10939
Study 28194729 — intervention group
Group type: COMPARATOR
Intervention: Control group (no decision support tool)
Number of subjects: 10939
Study 26051163 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational 'Lung Age' feedback
Number of subjects: 225
Study 26051163 — intervention group
Group type: COMPARATOR
Intervention: Minimal feedback (Control)
Number of subjects: 225
Study 23423433 — intervention group
Group type: EXPERIMENTAL
Intervention: Killed Leishmania (Leishmania) amazonensis vaccine
Number of subjects: 108
Study 23423433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 22189927 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 17
Study 22189927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 18036764 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer with cognitive and behavioral support materials (n=51)
Number of subjects: 103
Study 18036764 — intervention group
Group type: COMPARATOR
Intervention: Pedometer without cognitive and behavioral support materials (n=52)
Number of subjects: 103
Study 15921331 — intervention group
Group type: EXPERIMENTAL
Intervention: LongoVital (LV)
Number of subjects: 50
Study 15921331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11887037 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) therapy and Selenium (Se) supplementation
Number of subjects: 3
Study 11887037 — intervention group
Group type: COMPARATOR
Intervention: Erythropoietin (EPO) alone
Number of subjects: 3
Study 11887037 — intervention group
Group type: COMPARATOR
Intervention: Selenium (Se) supplementation
Number of subjects: 3
Study 10703146 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrastromal corneal ring segments (ICRS)
Number of subjects: 74
Study 9170575 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg (125 mg x 2)
Number of subjects: 30
Study 9170575 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide 375 mg (125 mg x 3)
Number of subjects: 30
Study 1751811 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (400 mg/8h)
Number of subjects: 30
Study 1751811 — intervention group
Group type: COMPARATOR
Intervention: Neomycin (1gr/8h)
Number of subjects: 30
Study 6627697 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (10 mg)
Number of subjects: 0
Study 6627697 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (10 mg)
Number of subjects: 0
Study 6627697 — intervention group
Group type: COMPARATOR
Intervention: Benserazide (200 mg)
Number of subjects: 0
Study 6627697 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (1 mg)
Number of subjects: 0
Study 6627697 — intervention group
Group type: COMPARATOR
Intervention: Benserazide
Number of subjects: 0
Study 31783823 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral esketamine as add-on to regular antidepressant medications for 6 weeks
Number of subjects: 0
Study 31783823 — intervention group
Group type: COMPARATOR
Intervention: Placebo as add-on to regular antidepressant medications for 6 weeks
Number of subjects: 0
Study 30541593 — intervention group
Group type: COMPARATOR
Intervention: Clinical information-based fluid management
Number of subjects: 244
Study 27239794 — intervention group
Group type: EXPERIMENTAL
Intervention: Process and mortality reporting (2008-2012)
Number of subjects: 20707266
Study 27239794 — intervention group
Group type: COMPARATOR
Intervention: Process-only reporting (2005-2007)
Number of subjects: 20707266
Study 27239794 — intervention group
Group type: COMPARATOR
Intervention: Nonreported conditions (secular control)
Number of subjects: 20707266
Study 25046410 — intervention group
Group type: EXPERIMENTAL
Intervention: Grosse‐Kempf nail
Number of subjects: 84
Study 25046410 — intervention group
Group type: EXPERIMENTAL
Intervention: Russell‐Taylor nail
Number of subjects: 84
Study 25046410 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthes nail
Number of subjects: 84
Study 22101419 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopy (SILS)
Number of subjects: 20
Study 22101419 — intervention group
Group type: COMPARATOR
Intervention: Conventional Laparoscopy
Number of subjects: 20
Study 19290703 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM) plus standard methadone treatment for 12 weeks
Number of subjects: 191
Study 19290703 — intervention group
Group type: COMPARATOR
Intervention: Standard methadone treatment
Number of subjects: 191
Study 18416737 — intervention group
Group type: EXPERIMENTAL
Intervention: basiliximab, calcineurin inhibitor, sirolimus and steroids
Number of subjects: 274
Study 15747721 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary enteral nutrition through nasogastric tube
Number of subjects: 32
Study 15747721 — intervention group
Group type: COMPARATOR
Intervention: Conventional liquid diet
Number of subjects: 32
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Reinforcement Plan (TRP) - rewarded up to $15 per week for task completion
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Reinforcement Plan (TRP)
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to therapy attendance
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to obtaining public entitlements
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to medical/psychiatric appointments
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to obtaining Medicaid
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to HIV testing/education
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to managing money
Number of subjects: 57
Study 12014813 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasks related to legal matters
Number of subjects: 57
Study 10408073 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol patch 0.05 mg daily for 3 weeks (Group 1)
Number of subjects: 42
Study 10408073 — intervention group
Group type: COMPARATOR
Intervention: No hormone replacement (Group 2)
Number of subjects: 42
Study 7500464 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral evaporation of the prostate
Number of subjects: 64
Study 7500464 — intervention group
Group type: COMPARATOR
Intervention: Visual laser ablation of the prostate
Number of subjects: 64
Study 2149049 — intervention group
Group type: EXPERIMENTAL
Intervention: Teicoplanin plus aztreonam
Number of subjects: 70
Study 2149049 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin plus piperacillin
Number of subjects: 70
Study 394794 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate injections
Number of subjects: 57
Study 394794 — intervention group
Group type: COMPARATOR
Intervention: Flupenthixol decanoate injections
Number of subjects: 57
Study 29804484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation of umbilical cord lengths using a new method
Number of subjects: 681
Study 29804484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation for predicting short umbilical cords
Number of subjects: 681
Study 29804484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation for predicting long umbilical cords
Number of subjects: 681
Study 30285695 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen-driven nebulisation
Number of subjects: 90
Study 30285695 — intervention group
Group type: COMPARATOR
Intervention: Air-driven nebulisation
Number of subjects: 90
Study 26755543 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study 25259426 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketorolac (n=46)
Number of subjects: 105
Study 25259426 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=59)
Number of subjects: 105
Study 22407900 — intervention group
Group type: EXPERIMENTAL
Intervention: Dong-Kook Montelukast Sodium Chewable Tablet 5 mg
Number of subjects: 32
Study 22407900 — intervention group
Group type: COMPARATOR
Intervention: Singulair Chewable Tablet 5 mg
Number of subjects: 32
Study 21194608 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (generic risperidone tablet)
Number of subjects: 22
Study 21194608 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (branded risperidone tablet)
Number of subjects: 22
Study 21194608 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 22
Study 17662757 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help book with seven weekly phone calls
Number of subjects: 72
Study 17662757 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 72
Study 15970632 — intervention group
Group type: EXPERIMENTAL
Intervention: Stalevo (levodopa, carbidopa, entacapone)
Number of subjects: 176
Study 15970632 — intervention group
Group type: COMPARATOR
Intervention: levodopa/DDCI plus entacapone (Comtess/Comtan)
Number of subjects: 176
Study 12584871 — intervention group
Group type: EXPERIMENTAL
Intervention: High-structure, behaviorally-oriented (HSB) individual counseling
Number of subjects: 0
Study 12584871 — intervention group
Group type: COMPARATOR
Intervention: Low-structure, facilitative (LSF) individual counseling
Number of subjects: 0
Study 10354805 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary tasks with different cognitive processing combinations (orthographic, phonemic, and semantic)
Number of subjects: 0
Study 10354805 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized secondary task techniques
Number of subjects: 0
Study 7864421 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 20 micrograms/kg
Number of subjects: 42
Study 7864421 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 10 micrograms/kg
Number of subjects: 42
Study 7864421 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 15 micrograms/kg
Number of subjects: 42
Study 7864421 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium 10 micrograms/kg, 15 micrograms/kg, and 20 micrograms/kg
Number of subjects: 42
Study 2040254 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% COHb exposure
Number of subjects: 63
Study 2040254 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.9% COHb exposure
Number of subjects: 63
Study 7126399 — intervention group
Group type: EXPERIMENTAL
Intervention: i.m. Glycopyrrolate 7.5 micrograms kg‐1
Number of subjects: 160
Study 7126399 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. Atropine 15 micrograms kg‐1
Number of subjects: 160
Study 7126399 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anticholinergic premedication)
Number of subjects: 160
Study 7126399 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 160
Study 30526280 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week EF instruction exercises
Number of subjects: 32
Study 29563636 — intervention group
Group type: EXPERIMENTAL
Intervention: nintedanib (200 mg bid)
Number of subjects: 93
Study 29563636 — intervention group
Group type: COMPARATOR
Intervention: sorafenib (400 mg bid)
Number of subjects: 93
Study 29563636 — intervention group
Group type: EXPERIMENTAL
Intervention: nintedanib
Number of subjects: 93
Study 29563636 — intervention group
Group type: COMPARATOR
Intervention: sorafenib
Number of subjects: 93
Study 27976604 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided crockery set (CS)
Number of subjects: 29
Study 27976604 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibrated serving spoon set (SS)
Number of subjects: 29
Study 27976604 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tools (CS and SS)
Number of subjects: 29
Study 24287077 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive intraoperative peritoneal lavage + arm
Number of subjects: 300
Study 24287077 — intervention group
Group type: COMPARATOR
Intervention: Extensive intraoperative peritoneal lavage - arm
Number of subjects: 300
Study 23622850 — intervention group
Group type: EXPERIMENTAL
Intervention: ARC intervention
Number of subjects: 393
Study 23622850 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 393
Study 21158329 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g intravenous paracetamol
Number of subjects: 60
Study 21158329 — intervention group
Group type: COMPARATOR
Intervention: 1 g intravenous paracetamol
Number of subjects: 60
Study 18528411 — intervention group
Group type: EXPERIMENTAL
Intervention: PulsePen
Number of subjects: 50
Study 18528411 — intervention group
Group type: EXPERIMENTAL
Intervention: Complior
Number of subjects: 50
Study 18528411 — intervention group
Group type: EXPERIMENTAL
Intervention: PulseTrace
Number of subjects: 50
Study 18528411 — intervention group
Group type: COMPARATOR
Intervention: Reference method (simultaneous acquisition of pressure waves using two tonometers)
Number of subjects: 50
Study 16671428 — intervention group
Group type: EXPERIMENTAL
Intervention: SAH patients
Number of subjects: 143